ARQIS advises ArchiMed on the acquisition of Zyto Group
()ARQIS has advised ArchiMed on the acquisition of Germany’s Zyto Group of cancer diagnostics companies in partnership with owners and management. With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer.